APO RESEARCH · REPORT
Oligonucleotides
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Product & engineering
Understand the product.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Selected research
Industry Growth & Trends
Global Oligonucleotides Industry Growth and Trends Forecast to 2032
Market perspective
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
According to APO Research, the global Oligonucleotides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Oligonucleotides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oligonucleotides market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oligonucleotides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oligonucleotides.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Oligonucleotides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oligonucleotides Market by Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Oligonucleotides Segment by Type
DNA Oligos
RNA Oligos
Oligonucleotides Segment by Application
Pharmaceutical
Research
Diagnostic
Oligonucleotides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Oligonucleotides companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Oligos
- RNA Oligos
Applications
- Pharmaceutical
- Research
- Diagnostic
Companies covered
- Integrated DNA Technologies
- Agilent
- Sigma-aldrich
- Eurofins Genomics
- L.G.C Biosearch Technologies
- Eurogentec S.A
- Nitto Denko Avecia Inc
- GenScript
- BBI Life Sciences
- GeneDesign
- TriLink BioTechnologies
- SGS DNA
- LC Sciences
- Twist Bioscience
- Creative Biogene
- General Biosystems
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Oligonucleotides Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Oligonucleotides Market Size by Region (2021-2032)
- 1.4.1 Global Oligonucleotides Market Size by Region (2021-2026)
- 1.4.2 Global Oligonucleotides Market Size by Region (2027-2032)
- 1.5 Key Regions Oligonucleotides Market Size (2021-2032)
- 1.5.1 North America Oligonucleotides Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Oligonucleotides Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Oligonucleotides Market Size Growth Rate (2021-2032)
- 1.5.4 South America Oligonucleotides Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Oligonucleotides Market Size Growth Rate (2021-2032)
2 Oligonucleotides Market by Type
- 2.1 Type Introduction
- 2.1.1 DNA Oligos
- 2.1.2 RNA Oligos
- 2.2 Global Oligonucleotides Market Size by Type
- 2.2.1 Global Oligonucleotides Market Size Overview by Type (2021-2032)
- 2.2.2 Global Oligonucleotides Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Oligonucleotides Market Size Forecasted by Type (2027-2032)
- 2.3 Global Oligonucleotides Market Size by Regions
- 2.3.1 North America Oligonucleotides Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Oligonucleotides Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Oligonucleotides Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Oligonucleotides Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Oligonucleotides Market Size Breakdown by Type (2021-2026)
3 Oligonucleotides Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical
- 3.1.2 Research
- 3.1.3 Diagnostic
- 3.2 Global Oligonucleotides Market Size by Application
- 3.2.1 Global Oligonucleotides Market Size Overview by Application (2021-2032)
- 3.2.2 Global Oligonucleotides Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Oligonucleotides Market Size Forecasted by Application (2027-2032)
- 3.3 Global Oligonucleotides Market Size by Regions
- 3.3.1 North America Oligonucleotides Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Oligonucleotides Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Oligonucleotides Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Oligonucleotides Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Oligonucleotides Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Oligonucleotides Industry Trends
- 4.2 Oligonucleotides Industry Drivers
- 4.3 Oligonucleotides Industry Opportunities and Challenges
- 4.4 Oligonucleotides Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Oligonucleotides Revenue (2021-2026)
- 5.2 Global Oligonucleotides Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Oligonucleotides Key Company Headquarters & Area Served
- 5.4 Global Oligonucleotides Company, Product Type & Application
- 5.5 Global Oligonucleotides Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Oligonucleotides Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Oligonucleotides Players Market Share by Revenue in 2025
- 5.6.3 2025 Oligonucleotides Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Integrated DNA Technologies
- 6.1.1 Integrated DNA Technologies Company Information
- 6.1.2 Integrated DNA Technologies Business Overview
- 6.1.3 Integrated DNA Technologies Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Integrated DNA Technologies Oligonucleotides Product Portfolio
- 6.1.5 Integrated DNA Technologies Recent Developments
- 6.2 Agilent
- 6.2.1 Agilent Company Information
- 6.2.2 Agilent Business Overview
- 6.2.3 Agilent Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Agilent Oligonucleotides Product Portfolio
- 6.2.5 Agilent Recent Developments
- 6.3 Sigma-aldrich
- 6.3.1 Sigma-aldrich Company Information
- 6.3.2 Sigma-aldrich Business Overview
- 6.3.3 Sigma-aldrich Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sigma-aldrich Oligonucleotides Product Portfolio
- 6.3.5 Sigma-aldrich Recent Developments
- 6.4 Eurofins Genomics
- 6.4.1 Eurofins Genomics Company Information
- 6.4.2 Eurofins Genomics Business Overview
- 6.4.3 Eurofins Genomics Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Eurofins Genomics Oligonucleotides Product Portfolio
- 6.4.5 Eurofins Genomics Recent Developments
- 6.5 L.G.C Biosearch Technologies
- 6.5.1 L.G.C Biosearch Technologies Company Information
- 6.5.2 L.G.C Biosearch Technologies Business Overview
- 6.5.3 L.G.C Biosearch Technologies Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 L.G.C Biosearch Technologies Oligonucleotides Product Portfolio
- 6.5.5 L.G.C Biosearch Technologies Recent Developments
- 6.6 Eurogentec S.A
- 6.6.1 Eurogentec S.A Company Information
- 6.6.2 Eurogentec S.A Business Overview
- 6.6.3 Eurogentec S.A Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Eurogentec S.A Oligonucleotides Product Portfolio
- 6.6.5 Eurogentec S.A Recent Developments
- 6.7 Nitto Denko Avecia Inc
- 6.7.1 Nitto Denko Avecia Inc Company Information
- 6.7.2 Nitto Denko Avecia Inc Business Overview
- 6.7.3 Nitto Denko Avecia Inc Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Nitto Denko Avecia Inc Oligonucleotides Product Portfolio
- 6.7.5 Nitto Denko Avecia Inc Recent Developments
- 6.8 GenScript
- 6.8.1 GenScript Company Information
- 6.8.2 GenScript Business Overview
- 6.8.3 GenScript Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GenScript Oligonucleotides Product Portfolio
- 6.8.5 GenScript Recent Developments
- 6.9 BBI Life Sciences
- 6.9.1 BBI Life Sciences Company Information
- 6.9.2 BBI Life Sciences Business Overview
- 6.9.3 BBI Life Sciences Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 BBI Life Sciences Oligonucleotides Product Portfolio
- 6.9.5 BBI Life Sciences Recent Developments
- 6.10 GeneDesign
- 6.10.1 GeneDesign Company Information
- 6.10.2 GeneDesign Business Overview
- 6.10.3 GeneDesign Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 GeneDesign Oligonucleotides Product Portfolio
- 6.10.5 GeneDesign Recent Developments
- 6.11 TriLink BioTechnologies
- 6.11.1 TriLink BioTechnologies Company Information
- 6.11.2 TriLink BioTechnologies Business Overview
- 6.11.3 TriLink BioTechnologies Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 TriLink BioTechnologies Oligonucleotides Product Portfolio
- 6.11.5 TriLink BioTechnologies Recent Developments
- 6.12 SGS DNA
- 6.12.1 SGS DNA Company Information
- 6.12.2 SGS DNA Business Overview
- 6.12.3 SGS DNA Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 SGS DNA Oligonucleotides Product Portfolio
- 6.12.5 SGS DNA Recent Developments
- 6.13 LC Sciences
- 6.13.1 LC Sciences Company Information
- 6.13.2 LC Sciences Business Overview
- 6.13.3 LC Sciences Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 LC Sciences Oligonucleotides Product Portfolio
- 6.13.5 LC Sciences Recent Developments
- 6.14 Twist Bioscience
- 6.14.1 Twist Bioscience Company Information
- 6.14.2 Twist Bioscience Business Overview
- 6.14.3 Twist Bioscience Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Twist Bioscience Oligonucleotides Product Portfolio
- 6.14.5 Twist Bioscience Recent Developments
- 6.15 Creative Biogene
- 6.15.1 Creative Biogene Company Information
- 6.15.2 Creative Biogene Business Overview
- 6.15.3 Creative Biogene Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Creative Biogene Oligonucleotides Product Portfolio
- 6.15.5 Creative Biogene Recent Developments
- 6.16 General Biosystems
- 6.16.1 General Biosystems Company Information
- 6.16.2 General Biosystems Business Overview
- 6.16.3 General Biosystems Oligonucleotides Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 General Biosystems Oligonucleotides Product Portfolio
- 6.16.5 General Biosystems Recent Developments
7 North America
- 7.1 North America Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Oligonucleotides Market Size by Country (2021-2026)
- 7.3 North America Oligonucleotides Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Oligonucleotides Market Size by Country (2021-2026)
- 8.3 Europe Oligonucleotides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Oligonucleotides Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Oligonucleotides Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Oligonucleotides Market Size by Country (2021-2026)
- 10.3 South America Oligonucleotides Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Oligonucleotides Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Oligonucleotides Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst